Citigroup
CURX

Citigroup’s Curanex Pharmaceuticals CURX Stock Holding History

Citigroup’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38K Sell
448
-519
-54% -$3.78K ﹤0.01% 5371
2026
Q1 		$9.88K Buy
+967
New +$7.26K ﹤0.01% 5046

Other funds holding CURX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Citigroup's CURX Position: Q2 2026 in Review

Citigroup reduced its Curanex Pharmaceuticals (CURX) stake by 54% in Q2 2026, selling an estimated $3.78K and leaving 448 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #5371.

Citigroup first reported a position in CURX in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.88K in Q1 2026. 11 funds tracked by Wall St. Rank hold CURX as of Q2 2026.

  • Citigroup held 448 shares of Curanex Pharmaceuticals worth $2.38K as of Q2 2026.
  • Citigroup sold 519 Curanex Pharmaceuticals shares in Q2 2026, an estimated $3.78K.
  • Curanex Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5371 holding.
  • Citigroup first reported a position in Curanex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Citigroup's Curanex Pharmaceuticals position peaked at $9.88K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.